Read more
Digital Access or Illicit Return? Restricting Telemedicine Could Drive 42% Back to Underground: Industry Insiders Weigh In
"As Germany debates cracking down on tele-clinics and flower sales, all eyes are on patient experience disruptions," Sassano said."Reversing course...
Read more
149_Michael Sassano, Master Multi-Country Operator
From Wall Street to Lisbon, from real estate to cannabis pharmaceuticals — Michael Sassano’s journey is anything but ordinary. In this...
Read more
Australia’s White-Label Identity Crisis: A Story of Quality, Branding and Margins
As the medical cannabis industry in Australia continues to boom with more patients than ever and the most modern products...
Read more
The New Era of Cannabis in Switzerland, Open Access and Education Lead B SOMAÍ and Dascoli Pharma Partnership
Switzerland has long been a country that wants to create a safe and sustainable future for its population — and...
Read more
SOMAÍ and Lusófona University Publish Peer-Reviewed Study Showcasing Best Practices in Full-Spectrum Cannabis Oil Production
Lisbon, Portugal — [1 July 2025] — SOMAÍ, a leading EU-GMP-certified vertically integrated Multi-Country Operator (MCO) specializing in cannabinoid-based medicines,...
Read more
Michael Sassano about global – Benzinga Cannabis Capital Conference
Throwback to Benzinga’s Cannabis Capital Conference in Chicago — where our Founder & Interim CEO, Michael Sassano, sat down for...
Read more
SOMAÍ Partners with Cookies Creative Consulting & Promotions, Inc. to Launch Berner’s Signature Series in Australia
We’re proud to announce a major milestone: SOMAÍ is partnering with Cookies Creative Consulting & Promotions, Inc. of California (Cookies...
Read more
SOMAÍ Launches New HCP Portals and AI Assistant as Part of Global Website Enhancements
SOMAÍ has announced the launch of dedicated HCP portals in Australia, Germany, and the United Kingdom, as well as the...